ArticleThe journal of allergy and clinical immunology. Global2026

The AIM4 Next Step study: Comparing inhaled corticosteroid dose escalation to dupilumab in patients with uncontrolled asthma and type 2 inflammation.

William W Busse et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.